Bellan Cristiana, Lazzi Stefano, Hummel Michael, Palummo Nazzareno, de Santi Margherita, Amato Teresa, Nyagol Joshua, Sabattini Elena, Lazure Thierry, Pileri Stefano A, Raphael Martine, Stein Harald, Tosi Piero, Leoncini Lorenzo
Department of Human Pathology and Oncology, University of Siena, Italy.
Blood. 2005 Aug 1;106(3):1031-6. doi: 10.1182/blood-2005-01-0168. Epub 2005 Apr 19.
The normal counterpart of the neoplastic B cells in Burkitt lymphoma (BL) is still unclear. Based on immunoglobulin gene rearrangement studies, some authors suggest an origin from germinal center cells and others from memory B cells. However, most of these studies rely on cell lines or on a small series of cases. To help clarify the cell of origin of BL, semi-nested polymerase chain reaction (PCR) was performed to amplify the VDJ rearrangements of the immunoglobulin heavy chain (V(H)) genes, and the resultant amplificates were sequenced for comparison with known germline V(H) segments. The results of this approach revealed that all cases (15 endemic BL [eBL], 10 sporadic BL [sBL], and 6 AIDS-related BL) harbor mutated V(H) genes, with different mutation ranges among the 3 types of BL. The eBL and AIDS-related forms showed considerably higher mutation rates than the sBL form (5.1%, 5.4%, and 1.5%, respectively). The mutations in eBL and AIDS-related BL also showed signs of antigen selection, whereas no signs of antigen selection were found in sBL. Finally, after subcloning the amplificates, sequence analysis revealed no signs of ongoing mutations in any of the cases analyzed. Given that one of the main differences between eBL and AIDS-related BL on the one hand and sBL on the other hand is the association with Epstein-Barr virus (EBV), we compared EBV-positive and EBV-negative BLs independently of their geographic origin and HIV status. The differences in the number of somatic mutations and antigen selection were even more evident when this approach was used. According to our molecular results, it appears that EBV-positive and EBV-negative BL may originate from 2 distinct subsets of B cells, pointing to a particular role for the germinal-center reaction in the pathogenesis of these tumors. The different types of C-MYC translocation reported in BL may also be related to the different stages of B-cell maturation.
伯基特淋巴瘤(BL)中肿瘤性B细胞的正常对应物仍不清楚。基于免疫球蛋白基因重排研究,一些作者认为其起源于生发中心细胞,另一些作者则认为起源于记忆B细胞。然而,这些研究大多依赖细胞系或少量病例。为了帮助阐明BL的起源细胞,我们进行了半巢式聚合酶链反应(PCR)以扩增免疫球蛋白重链(V(H))基因的VDJ重排,并对所得扩增产物进行测序,以便与已知的种系V(H)区段进行比较。该方法的结果显示,所有病例(15例地方性BL [eBL]、10例散发性BL [sBL]和6例艾滋病相关BL)均含有突变的V(H)基因,3种类型的BL之间的突变范围不同。eBL和艾滋病相关类型的突变率明显高于sBL类型(分别为5.1%、5.4%和1.5%)。eBL和艾滋病相关BL中的突变也显示出抗原选择的迹象,而在sBL中未发现抗原选择的迹象。最后,在对扩增产物进行亚克隆后,序列分析显示在所分析的任何病例中均未发现正在进行的突变迹象。鉴于eBL和艾滋病相关BL与sBL之间的主要差异之一是与爱泼斯坦-巴尔病毒(EBV)的关联,我们独立于其地理起源和HIV状态比较了EBV阳性和EBV阴性BL。当采用这种方法时,体细胞突变数量和抗原选择的差异更加明显。根据我们的分子结果,似乎EBV阳性和EBV阴性BL可能起源于B细胞的2个不同亚群,这表明生发中心反应在这些肿瘤的发病机制中起特定作用。BL中报道的不同类型的C-MYC易位也可能与B细胞成熟的不同阶段有关。